the growing epidemic of type 2 diabetes is one of the leading causes of premature morbidity and mortality worldwide mainly due to the micro and macrovascular complications associated with the diseasea growing body of evidence suggests that although the risk of developing complications is greater with glucose levels beyond the established threshold for diagnosisincreasing in parallel with rising hyperglycemiaindividuals with glucose levels in the prediabetic range are already at increased riskearly intervention ideally as soon as abnormalities in glucose homeostasis are detected is of great importance to minimize the burden of the diseasehowever as the early stages of the disease are asymptomatic diagnosing prediabetes and early overt type 2 diabetes is challengingthe aim of this article is to discuss these challenges the benefits of early interventionwith emphasis on the prevention trials showing that progression to type 2 diabetes can be delayed by addressing prediabetesand the existing evidencebased guidelines that have been drawn to optimize the standards of care at the prediabetes and overt type 2 diabetes stagescopyright  2013published by elsevier inc